The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 03, 2020
Filed:
Aug. 06, 2020
Applicant:
King Abdulaziz University, Jeddah, SA;
Inventors:
Moustafa E. El-Araby, Jeddah, SA;
Abdelsattar Mansour Omar, Jeddah, SA;
Mahmoud Abdelkhalek El-Faky, Jeddah, SA;
Sameh Hamdy Abdelmageed Soror, Jeddah, SA;
Maan Talaat Khayat, Jeddah, SA;
Hani Zakariah Asfour, Jeddah, SA;
Faida Hassan Bamane, Jeddah, SA;
Assignee:
King Abdulaziz University, Jeddah, SA;
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/4164 (2006.01); A61K 31/55 (2006.01); C07D 233/64 (2006.01); C07D 233/54 (2006.01); C07C 279/04 (2006.01); C07C 279/10 (2006.01); C07C 279/12 (2006.01); C07D 279/16 (2006.01); A61P 31/14 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4164 (2013.01); A61P 31/14 (2018.01);
Abstract
Imidazole-based compounds as hepatitis C virus (HCV) inhibitors. The compounds have an imidazole core that is disubstituted via amide links. Also described are a pharmaceutical composition incorporating the imidazole-based compound, a method of preparing these compounds, and a method for using the pharmaceutical composition in the treatment of HCV infection.